Trump’s FDA nominee faces Senate questions after agency layoffs and resignations
Dr. Marty Makary will answer questions from a Senate panel about his plans to lead the Food and Drug Administration.
Trump’s FDA nominee, Marty Makary, faces his first test
Marty Makary, Trump’s pick for FDA director, faces his first test as he testifies before the Senate health committee.
Through ‘radical transparency,’ Kennedy can finally rein in Big Pharma
Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...
Trump's FDA chief pick Makary to face overhauling agency, keeping Kennedy happy
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, will be tasked with maintaining the agency's gold ...
F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
Medscape6h
As Trump Administration Probes Long-Approved Medications, Could FDA Revoke Approvals?
A new federal commission will ‘investigate’ decades-old mental health as well as weight loss drugs, prompting concerns from ...
FDA recalls common Chinese food ingredient after undeclared sulfites found in Florida inspection
A brand of dried lily flowers have been recalled by the U.S. Food and Drug Administration after undeclared sulfites were ...
STAT3h
Live updates: Marty Makary, Trump’s pick for FDA commissioner, testifies before Senate panel
Marty Makary, Trump’s pick for FDA commissioner, testifies before a Senate panel this morning. Follow STAT's live updates.
US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
What to Know About Marty Makary, Trump’s Pick to Lead the FDA
If confirmed, Makary would run one of the nation's leading health agencies, overseeing the regulation of food and drugs.
ImmunityBio Receives FDA RMAT Designation for ANKTIVA and CAR-NK (PD-L1 t-haNK) to Achieve Reversal of Lymphopenia in Pancreatic Cancer Patients
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...
FDA pick may differ from HHS head RFK Jr. on some key areas
Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health ...